Deep Polymers (541778)
Slow GrowerScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹77.81 |
| Market Cap | ₹188.14 Cr |
| P/E Ratio | 16.16 |
| ROCE | 8.06% |
| ROE | 5.14% |
| Dividend Yield | 0% |
| Profit Growth | -5.85% |
| Debt/Equity | — |
| Sales Growth | 3.21% |
| 52-Week Range | ₹28.4 — ₹77.81 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹37.13 |
Strengths
- Positive net profit margin of ~7.7% in the latest quarter (₹2 Cr profit on ₹26 Cr sales)
- P/B of 2.10 is not extreme relative to book value of ₹37.13
- 52-week price action shows strong market interest, potentially indicating a business inflection
- Sales are still growing, albeit slowly at 3.21%, showing some demand resilience
Concerns
- Earnings declined 5.85% while the stock trades near its 52-week high, creating valuation risk
- Low returns on equity (5.14%) and capital (8.06%) indicate weak franchise economics
- Piotroski F-Score of 4/9 signals fundamental deterioration
- No dividend yield and a PEG of 5.03 make the risk-reward unattractive for value investors
AI Analysis
Let's look at Deep Polymers as Graham would: a small specialty chemicals player at ₹77.81, market cap ₹188 Cr. The stock has nearly tripled from its 52-week low of ₹28.40, yet the underlying business is not growing fast. Sales grew only 3.21% and profits actually fell 5.85%. At a P/E of 16.16, you are paying a decent multiple for negative earnings momentum—that is not a recipe for value. The balance sheet shows a book value of ₹37.13, so the stock trades at 2.1 times book. For a company earning just 5.14% ROE and 8.06% ROCE, that premium demands real future improvement, not just hope. The Piotroski F-Score of 4 out of 9 is a red flag; it suggests deteriorating fundamentals—weak profitability, possible asset or margin issues, and poor operating efficiency. The PEG ratio of 5.03 reinforces the point: growth is too slow to justify the price. There is no dividend to compensate you while you wait. This is a business without a clear moat in a competitive specialty chemicals space. What I like is that the latest quarter shows sales of ₹26 Cr and net profit of ₹2 Cr, a margin near 7.7%, which is respectable. But one quarter doesn't make a trend. As a value investor, I need a margin of safety. At this price, with declining profits and low returns on capital, I find no such margin. This looks like a slow grower that got ahead of itself in a market rally. I'd stay on the sidelines unless the price falls closer to book value or earnings show consistent double-digit growth.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer